Warsaw-based Biomet Inc. has completed a deal to buy a Colorado-based spinal technology manufacturer. Biomet Spine, Bone Healing & Microfixation President Adam Johnson says the Lanx Inc. acquisition helps position the company for “significant growth” in a key market. November 1, 2013

News Release

WARSAW, Ind. – Biomet, Inc., a global leader in the manufacture of musculoskeletal and biotechnology products, announced today the closing of the previously announced acquisition of Lanx, Inc., a full service spine company and a leader in minimally invasive techniques and technologies.

Adam Johnson, President of Biomet Spine, Bone Healing & Microfixation, stated, “We are pleased to finalize the acquisition and begin the integration of the two companies into a stronger spine presence for Biomet. We welcome the Lanx team and distributors to the Biomet family and look forward to working together to fulfill our vision for significant growth in this strategically important market for Biomet.”

About Biomet

Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet's product portfolio includes knee and hip reconstructive products; sports medicine, extremities and trauma products; spine, bone healing and microfixation products, including spine hardware, spinal stimulation devices, osteobiologics, and non-invasive bone growth stimulators; as well as neurosurgical and craniomaxillofacial reconstructive devices, and thoracic products; dental reconstructive products; and bone cement products, biologics, and other products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.

Source: Biomet Inc.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}